Provider review
Nurx review
Publishes cash prices for six branded GLP-1s, and they are the real ones.
No compounded route and no low-dose product — but the branded cash figures are the reference point every compounded seller here is quietly priced against.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Nurx
$650–$1,300/mo branded cash prices, no compounded option
- Vs median
- $481/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Not a compounded product
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Nurx does not sell a compounded preparation and does not pretend the approved products are cheap. It publishes a cash price for six branded GLP-1s, and those figures sit around a thousand dollars a month and above. For a reader on this site that is worth more than it first looks, because almost every compounded seller reviewed here is priced against exactly these numbers without ever naming them. Seeing the branded cash price written down is what turns that comparison from rhetoric into arithmetic. The site also advertises weight-management treatment for as little as nothing with insurance, and that is a coverage outcome rather than a price — what you actually pay depends on a plan you have to go and check, and the distance between that headline and the cash figures beside it is very wide indeed. For the specific question this site exists to answer there is nothing here: no low-dose product, no microdose lane, no compounded option. But the reference point is a good one, and unlike most of the field it is published rather than implied.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see what the approved products actually cost without insurance.
- You want approved medication with no compounding question at all.
- You want a cheaper non-GLP-1 oral option priced alongside for comparison.
Look elsewhere if
- You are looking for a low dose. No low-dose product is offered.
- You are price-shopping. These are several times the compounded figures here.
- You are relying on the no-cost headline. That is an insurance outcome, not a price.
What it actually costs
Price as published
★ Branded cash prices published openly, per product: Zepbound and Mounjaro from about $1,000 a month on average, Ozempic about $1,000, Wegovy and Saxenda about $1,300, and Victoza about $650 · an oral bupropion and naltrexone option at $60/month sits well below all of them · the site also advertises weight-management treatment "for as low as $0 with insurance", which is a coverage outcome rather than a price · ★ these figures are useful precisely because they are high: they are roughly what the approved products cost without insurance, and they are the number every compounded seller on this site is implicitly comparing itself against · no compounded option is offered, and no low-dose product
- Vs median
- $481/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Cash prices are published per branded product, readable before intake, which is why both molecules are recorded. ★ They are useful as the reference point every compounded seller here is implicitly priced against. No low-dose product and no compounded route exists.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Publishes cash prices for six branded GLP-1s rather than quoting after an intake.
- Supplies approved products, so no compounding question arises at all.
- Prices a much cheaper non-GLP-1 oral option alongside them for comparison.
Pharmacy, labs and oversight
Nurx dispenses through a Not applicable — branded, FDA-approved products facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Nurx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Nurx does not sell a compounded preparation and does not pretend the approved products are cheap. It publishes a cash price for six branded GLP-1s, and those figures sit around a thousand dollars a month and above. For a reader on this site that is worth more than it first appears: almost every compounded seller here is priced against exactly these numbers without ever naming them, and seeing the branded cash price written down is what makes the comparison real rather than rhetorical. The site also advertises treatment for as little as nothing with insurance, which is a coverage outcome and not a price — what a reader actually pays depends on a plan they have to go and check, and the gap between that claim and the cash figures beside it is very wide. There is no low-dose product and no microdose lane, so for the specific question this site exists to answer there is nothing here beyond the reference point. But the reference point is a good one, and it is published rather than implied.
The honest cons
The cash figures are several times what the compounded sellers here charge.
- The "as low as $0" headline is an insurance outcome, not a price.
- No compounded route and no low-dose product of any kind.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Nurx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#201 of 373
Ordered with the companies that pay us first, and Nurx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.